Semax Research Peptide

For a peptide studied this widely, one basic question took a long time to answer: does Semax have its own docking point in brain tissue? Using tritium-labelled peptide and cell membranes prepared from the rat basal forebrain, the Moscow group measured binding that was time-dependent, reversible and specific, with a dissociation constant of about 2.4 nM and a maximum capacity close to 33.5 fmol per milligram of protein. Unusually, that binding only occurred when calcium ions were present (Learn more). The same paper found BDNF protein in the basal forebrain climbing within three hours of intranasal application in rats, while the cerebellum stayed unchanged, pointing to a regional effect rather than a brain-wide one.

The basal forebrain houses the cholinergic neurons that supply acetylcholine to the cortex and hippocampus, so it was a logical place to look. In primary cultures from this region, Semax raised survival of cholinergic neurons by roughly 1.5- to 1.7-fold and increased choline acetyltransferase activity at 100 nM, while counts of GABA-releasing neurons and the proliferation of glial cells were unaffected.

Semax is routinely grouped with the melanocortins, the family of peptides cut from pro-opiomelanocortin that includes ACTH and alpha-MSH. Yet the five melanocortin receptors (MC1R to MC5R) chiefly recognise a four-residue core, His-Phe-Arg-Trp, found at positions 6 to 9 of ACTH. Semax keeps the His-Phe half of that motif and then switches to Pro-Gly-Pro, so the arginine and tryptophan that classic melanocortin agonists rely on are absent. This is why the calcium-dependent binding site described above draws so much interest: it hints that Semax may act through something other than a textbook melanocortin receptor, though what that site actually is has not been settled.

A head-to-head study in male rats gave a useful benchmark by pairing Semax with Melanotan II, one of the most potent synthetic melanocortin agonists, in a chronic unpredictable stress model. Despite their very different structures, both peptides counteracted several of the same stress markers (Learn more), a result that keeps the receptor debate open.

A large part of the Semax stroke literature uses permanent occlusion of the middle cerebral artery in rats, a model in which blood flow is never restored. A genome-wide study of the ischaemic cortex at 3 and 24 hours found that the genes Semax shifted were dominated by the immune system: by the later time point, immune-response genes made up more than half of all Semax-responsive genes, with immunoglobulin and chemokine genes forming the most notable groups (Learn more). Vascular genes responded too, 24 of them at 3 hours and 12 at 24 hours, linked to endothelial development and migration, smooth-muscle cell migration and the formation of new vessels.

An earlier paper in the same model followed neurotrophin transcripts over three days. Semax lifted Bdnf, TrkA and TrkC at 3 hours, Nt-3 and Ngf at 24 hours, and Ngf again at 72 hours. The bare Pro-Gly-Pro tripeptide also raised several of these transcripts, but its influence was largely non-specific, whereas the Semax response was selective for the ischaemic cortex.

Short peptides rarely last long in biological fluids, and Semax research has mapped its breakdown in unusual detail. In rat blood and serum, a bestatin-sensitive aminopeptidase accounted for roughly a third to a half of the degrading activity, clipping methionine and then glutamic acid from the front of the molecule and leaving comparatively stable intermediates (Learn more). Against the remaining enzymes, Semax held up better than its parent fragment ACTH(4-10), and the authors argued that the intermediates persist long enough to share in the effects credited to the intact peptide.

Later work labelled every residue of Semax with tritium so that each fragment could be followed by HPLC. With rat basal forebrain membranes, glial cells and neurons, the main events were loss of Met-Glu from one end and Gly-Pro from the other, producing pentapeptides, although glial and neuronal cultures generated noticeably different fragment patterns.

A separate line of chemistry has grown up around the affinity of Semax for metal ions. It binds copper(II) strongly, and at around neutral pH the dominant complex arranges four nitrogen atoms in a flat, square pattern around the metal (Learn more). In SH-SY5Y neuroblastoma and RBE4 endothelial cell lines, Semax reduced copper-induced toxicity. Cell-free studies have since reported that it can pull copper away from amyloid-beta complexes, cutting copper-driven formation of reactive oxygen species and copper-promoted fibril growth in artificial membrane models.

Those results matter for analogue work. N-acetyl Semax, which carries an acetyl cap on its amino terminus, is widely listed online, and it has been compared directly with the parent peptide. The capped version formed a different copper complex, built from three nitrogens, an oxygen and a weak contact from the methionine sulphur, and it failed to protect SH-SY5Y cells from copper toxicity. The authors concluded that the free amino terminus is central to the protective result, even though both forms bound zinc with similar strength.